AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. META
3. NVDA
4. DCOY
5. SPY
6. MSFT
7. VKTX
8. PRGS
9. CMPX
10. GS

Go back to AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
AVIANCA HOLDINGS S.A. (NYSE: AVH) Delayed: 0.88 --0 (-0%)
Previous Close $0.88    52 Week High $7.65 
Open $28.14    52 Week Low $3.40 
Day High $0.88    P/E N/A 
Day Low $0.88    EPS $0.00 
Volume 12,888       

(NASDAQ: RCEL) Delayed: 11.49 +0.65 (6.00%)
Previous Close $10.84    52 Week High $ 
Open $10.86    52 Week Low $ 
Day High $11.81    P/E N/A 
Day Low $10.71    EPS $ 
Volume 525,412